We have moved to new location, Please click on contact us  
Home  >  News
you can get e-magazine links on WhatsApp. Click here
Events + Font Resize -

Citeline supports Informa Markets of CPhI & PMEC India Expo, at Greater Noida, Delhi NCR

Our Bureau, Bengaluru
Monday, December 5, 2022, 14:15 Hrs  [IST]

Citeline, formerly Informa Pharma Intelligence, one of the leading providers of drug, device, company, clinical trial and market intelligence in the pharmaceutical and med-tech markets played an intrinsic role in the recently concluded 022 edition of CPhI & PMEC India, a one-of-a-kind opportunity to interact with leading pharmaceutical companies and experts. It partnered with CPhI and Informa Markets as a Knowledge Partner for the Pre-Connect Congress and CPhl CEO round table during the conference.
Poornachandra Tejasvi, senior director, emerging markets, India, at Citeline said, “We have the opportunity to share important insights with leading pharmaceutical companies across the nation and the globe using real-time news, trends, market analysis, and specialist reports. Today, the Indian pharmaceutical market is expanding at a 15% annual rate, making it one of the strongest rising markets in the pharma industry world. While India’s generics market is expanding rapidly, it is also becoming a potential source for innovative medicines research and development with emphasis on biosimilars, complex generics, vaccines, and cell & gene therapy products as the next growth areas for the Indian Industry.
Pharmaceutical companies worldwide have a lot to gain from exploring and taking advantage of India and the CPhI & PMEC event is currently the only place in the country to go for everything pertaining to the most cutting-edge pharmaceutical solutions that the world has to offer. The venue will also accommodate the most recent and innovative solutions in the generics and pharmaceutical research and development segment. I look forward to being a part of this prestigious event and hope to reconnect with the stakeholders and peers in the industry to offer relevant data intelligence and analysis insights during the event, added Tejasvi.
“India has emerged to become the largest provider of generic drugs globally exporting to more than 200 countries, with the USA being an integral market. With the projections of rising medicine spending globally, this offers India a key opportunity to lead the world in this sector. To achieve this, there is an immediate need in the industry for companies to expand their manufacturing capabilities, invest in innovative technologies, focus on research and development, and enhance its distribution and export infrastructure. Therefore, it is  important to take this time and deliberate on the steps the industry can take to reach these goals, and CPhI & MPEC India provides the perfect platform to bring key thinkers and leaders from this sector together as they discuss these factors,” said Yogesh Mudras, managing director, Informa Markets in India.


* Name :     
* Email :    
  Website :  
India Lab Expo
Copyright © 2016 Saffron Media Pvt. Ltd |